Researchers at SAHMRI and the University of Adelaide have pinpointed a tumor support signal that works to suppress the immune system. Blocking this signal may prove pivotal in stopping bowel cancer.
Dec 8, 2021
0
6
Grouping of pathogen-recognizing proteins on immune T cells may be key to identifying if someone has had an infection in the past, suggests a study published today in eLife.
Nov 30, 2021
0
4
(HealthDay)—Lyss Stern lost her sense of smell when she was diagnosed with COVID-19 in March 2020, and it still hasn't returned.
Nov 18, 2021
0
36
Researchers have developed a model that could predict early on in treatment whether cancer patients will respond to immunotherapy, according to a report published today in eLife.
Nov 9, 2021
0
48
Mutations in blood cells likely caused by smoking and aging-related changes may lead to a rare type of blood cancer that affects immune cells, shows a study published today in eLife.
Sep 28, 2021
0
3
New research published in Stem Cell Reports has found elevated cholesterol supply from astrocytes to neurons in the model of Alzheimer's disease (AD) brains, suggesting that modulating brain cholesterol could be explored ...
Aug 26, 2021
0
387
Treating mice that have a Parkinson's disease-causing mutation with a small molecule compound restores the removal of damaged mitochondria from their brain cells, shows a study published today in eLife.
Aug 3, 2021
0
541
If Professor Thomas Rudel and the biopharmaceutical company Aeterna Zentaris GmbH have their way, there could possibly be significant enhancement in the fight against the global Corona pandemic in the future: a vaccination ...
Mar 26, 2021
0
5
For the first time, SAHMRI and University of Adelaide researchers are investigating gene therapy as an option to help people with metastatic bowel cancer.
Nov 26, 2020
0
59
German biotech company BioNTech and US pharmaceutical Pfizer announced on Monday promising early results from their phase 3 clinical trial for a vaccine against SARS-CoV-2, the virus that causes COVID-19.
Nov 10, 2020
0
3
